The expression of PLF in placenta in pregnancy-induced hypertension and the relationship between the PLF and serum VCAM-1

被引:0
|
作者
Xu, Xiaoyan [1 ]
Xiang, Wenpei [1 ]
Chen, Hanping [1 ]
机构
[1] Department of Obstetrics and Gynecology, Huazhong University of Science and Technology, Tongji Hospital, Wuhan 430030
来源
Journal of Huazhong University of Science and Technology - Medical Science | 2003年 / 23卷 / 02期
关键词
Blood - Cell culture - Genetic engineering - Histology - Immunology - Pathology - Pressure effects;
D O I
暂无
中图分类号
学科分类号
摘要
To study the expression of placental isoferritin (PLF) in placental tissue of pregnancy-induced hypertension (PIH) and the relationship between the level of expression of PLF and the amount of vascular cell adhesion molecule-1 (VCAM-1) in serum, immunohistochemical technique was used to detect the expression of PLF in placenta tissue in 45 PIH patients (PIH group) and 15 normal pregnant women (normal group). High resolution pathological image analysis system (HPIAS-100) was employed to determine the quantity of PLF. The VCAM-1 in serum was examined by enzyme linked immunoabsorbent assay (ELISA). The results showed that the levels of PLF expressions in moderate and severe PIH patients were significantly lower than that of normal group (P<0.01). The serum VCAM-1 was significantly decreased in PIH group (1310±177 p/ng/ml) than that of normal group (609±72 p/ng/ml, P<0.01). The significant negative correlation existed between the expression of PLF in placental tissue and the serum VACM-1 (r=-0.58, P<0.01). It was concluded that the level of PLF expression in PIH decreases and is negatively correlated with the amount of serum VCAM-1, indicating that these may be involved in the pathogenesis of PIH.
引用
收藏
页码:184 / 186
相关论文
共 50 条
  • [31] Serum levels of adhesion molecules in women with pregnancy-induced hypertension
    Zeisler, H
    Livingston, JC
    Schatten, C
    Tempfer, C
    Knöfler, M
    Husslein, P
    WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 (15-16) : 588 - 592
  • [32] SERUM LAMININ IN PREGNANCY-INDUCED HYPERTENSION - A MARKER FOR RENAL INVOLVEMENT
    RUDELSTORFER, R
    BIEGLMAYER, C
    NANZ, S
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1990, 30 (02) : 78 - 80
  • [33] Association between gestational diabetes and pregnancy-induced hypertension
    Bryson, CL
    Ioannou, GN
    Rulyak, SJ
    Critchlow, C
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (12) : 1148 - 1153
  • [34] The association between gestational diabetes and pregnancy-induced hypertension
    Bryson, CL
    Ioannou, G
    Rulyak, S
    Critchlow, C
    CIRCULATION, 2003, 107 (07) : E7032 - E7032
  • [35] SERUM DIGOXIN-LIKE SUBSTANCES IN PREGNANCY-INDUCED HYPERTENSION
    POSTON, L
    MORRIS, JF
    WOLFE, CD
    HILTON, PJ
    CLINICAL SCIENCE, 1989, 77 (02) : 189 - 194
  • [36] SERUM URIC-ACID AS A MARKER OF PREGNANCY-INDUCED HYPERTENSION
    HICKMAN, PE
    MICHAEL, CA
    POTTER, JM
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1982, 22 (04): : 198 - 202
  • [37] Serum C-reactive protein in pregnancy-induced hypertension
    Garmendia, JV
    De Rios, ZR
    Bianco, NE
    De Sanctis, JB
    MEDICAL SCIENCE RESEARCH, 1999, 27 (07): : 457 - 458
  • [38] RAISED SERUM GRAVIDIN LEVELS ARE ASSOCIATED WITH PREGNANCY-INDUCED HYPERTENSION
    WILSON, T
    AMERICAN JOURNAL OF PERINATOLOGY, 1993, 10 (02) : 168 - 171
  • [39] Elevated serum concentrations of androgens in women with pregnancy-induced hypertension
    Jirecek, S
    Joura, EA
    Tempfer, C
    Knöfler, M
    Husslein, P
    Zeisler, H
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (5-6) : 162 - 166
  • [40] Correlation between antiphospholipid antibodies and pregnancy-induced hypertension
    ElKabarity, H
    Hafez, SA
    Ammar, E
    Aki, S
    ElBadawi, N
    INCREASINGLY SAFE AND SUCCESSFUL PREGNANCIES: FOCUS: EPH GESTOSIS, 1996, 1107 : 345 - 349